Dr. Boatright is a Professor in the Department of Ophthalmology, Emory University School of Medicine and an Investigator and Director of the Molecular Biology Core of the Rehabilitation R&D Center for Visual and Neurocognitive Rehabilitation (CVNR) of the Atlanta Veterans Affairs Medical Center (VAMC). He is a graduate of Brown University (ScB in Neural Sciences and Experimental Psychology) and Emory University (PhD in Pharmacology and the Neurosciences Training Program). He joined Emory's faculty in 1999, conducting research on the regulation of retinal gene expression funded by an independent R01 grant from the National Institutes of Health National Eye Institute (NIH NEI). This research expanded into using endogenous DNA repair mechanisms to treat genetic mutations that lead to blindness, a separate project funded by an NEI R01.
In a separate project, Dr. Boatright uses in vivo pharmacological approaches to explore the effects of atypical, endogenous compounds on animal models of retinal degeneration and glaucoma. This work is funded by the Katz Foundation, Foundation Fighting Blindness, NIH National Center for Complementary and Alternative Medicine (NIH NCCAM), and a Merit Award from the Veterans Administration.
Dr. Boatright is founding and current editor-in-chief of Molecular Vision, a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology and the genetics of the visual system. The journal is in the top three in a field of 14 competing journals and is routinely used as an open access exemplar by the National Library of Medicine and The National Institutes of Health Library. The journal is supported by Knights Templar, Zhongshan Ophthalmic Center, and through initiatives generated in the Department of Ophthalmology. He also serves on the Editorial Review Boards of International Ophthalmology Times and the International Journal of Molecular Sciences. He is also the Visual Sciences Section Editor for the Asia-Pacific Journal of Ophthalmology.
Dr. Boatright was 2011-2012 president of the Association for Research in Vision and Ophthalmology (ARVO), the premier vision research organization in the United States and was a 2007-2013 ARVO Trustee. He was made ARVO Gold Fellow in 2012 in recognition of his accomplishments, leadership, and contributions to the Association. He also holds memberships in the American Association for the Advancement of Science, the Society for Neuroscience, the American Society of Neurorehabilitation, and the International Society for Eye Research.
Dr. Boatright is principal investigator (PI) or co-investigator in four NEI grants and two private foundation grants. He has also been recently awarded a VA SPiRE grant to study the effects of exercise on vision-related biomarkers in humans and mice.